Schwab Network on $MRK

Channel profile →Sources cited by the channel: BFA and JP Morgan, Baird, Bank of America, Barclays, Berenberg, Bernstein, Bernstein, with a Jefferies target cut noted, Bilal Little, Bird (analyst firm), CEO, CEO Joe Dominguez, Caner, Citi, Citigroup, Citizens, Daiwa, Dan Deming and Michael Monahan, Dan Ies; Morgan Stanley, Dan Ives, Dan Ives and unnamed analysts, Deutsche Bank, Erit Research, Evercore ISI, Evercore ISI; Dan Ives, Goldman Sachs, JP Morgan Chase, JPMorgan, JPMorgan Chase, James Demerard of Wall Street Research, Jefferies, Jefferies, UBS and Citigroup, Jensen Huang; Dan Ives, KeyBank, Loop Capital, Mattie Natsson, Michael Saylor, Milius (analyst), Morgan Stanley, Northrop, Oppenheimer, Oppenheimer, Freedom Broker, Oracle, PFA analysts, Quantum CEO, RBC, Reddit CEO, Rothschild Redburn, SK Hynix, Seth, Tim Bigham, Tim and KG, Truist, UBS, Wall Street Journal, Wedbush, Wells Fargo, analysts, the street2 entries

Schwab Network has discussed $MRK in 2 videos since 2026-09-09. The latest, on 2026-10-15, was bullish.

2026-10-15Bullish
“The Big 3: MRK, GILD, XOM”
AI summary · MRK is reversing its month-and-a-half downtrend and breaking out of a descending channel after a pullback from around 157; RSI momentum is turning up, and a long-term bull flag suggests about 170, with a possible breakout to new record highs of 165-170 next month. Not guaranteed; risks remain; earnings due soon.

Merck is your first choice and truly outperforms the market today. Its stock is up by 2%. They have an earnings announcement due at the end of this month. I am impressed with " Merck" here because it has started to reverse the downward trend it has been in for the past month and a half or so .

It looks like we may be breaking out of that down channel today, and it will be interesting to hear Ben's opinion , but I think there is a possibility of seeing higher price action now that the company has found some stability.

2026-09-09Bearish
“The Big 3: ROST, MRK, AAPL”
AI summary · Merck's current strength is viewed as a liability; the speaker anticipates a downside move and has positioned for it via a put spread expiring in ~100 days.

Uh another one with a big runup is Merc, which is your second pick here in the big three. They came out with a really positive trial news. perhaps were one step closer uh to curing melanoma or having at least a profound treatment for it.

Uh but losing, you know, maintaining their momentum. They're up about 14% but falling off of those highs. How are you looking at Merc?